OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands
Innovative best-in-class technology solutions continue to offer HCPs a seamless prescribing experience within the EHR workflow
The new agreement is an extension of the exclusive partnership between Therapy Brands and
“Therapy Brands is excited to renew this exclusive arrangement, which has been beneficial to both NewCrop and
“We continue to see great benefit in this partnership and are enthused that we’re extending this exclusive agreement,” commented
For more information, follow the Company on Twitter, LinkedIn or visit www.optimizerx.com.
About Therapy Brands
Therapy Brands is a leading healthcare IT partner for mental, behavioral, and rehabilitative therapy. Their electronic prescribing solution, NewCrop, has been deployed in a wide range of EHRs and medical networks since 2003. The company's user interface allows for rapid installation of fully expedited e-Prescription networking, lab integration, secure messaging, registry reporting, DEA-compliant EPCS audit, and more.
For more information, visit www.therapybrands.com
Important Cautions Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs, or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company’s growth, business plans, and future performance. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Company’s Annual Report on Form 10-K for the fiscal year ended
Andy D’Silva, SVP Corporate Finance
Media Relations Contact
Investor Relations Contact
Therapy Brands Media Relations Contact
Source: OptimizeRx Corporation